Jeffrey Eastham-Anderson

Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1

Meijuan Zhou, Min Xu, Zora Modrusan, 2013, Nature Immunology.

Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors

Lily Shao, Mark Merchant, Eva Lin, 2017, PloS one.

Blocking Vascular Endothelial Growth Factor-A Inhibits the Growth of Pituitary Adenomas and Lowers Serum Prolactin Level in a Mouse Model of Multiple Endocrine Neoplasia Type 1

Napoleone Ferrara, N. van Bruggen, F. Peale, 2008, Clinical Cancer Research.